Annexon Biosciences (ANNX) plans to offer 10M shares at a price of $14-$16 per share.
Proceeds will be used to fund clinical trials, R&D activities, for working capital and other general corporate purposes.
Previously: Annexon on deck for IPO (July 2)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.